Guggenheim Capital’s Dermira, Inc. DERM Stock Holding History

Guggenheim Capital’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-287,779	Closed	-$2.3M	–	2731
2018 Q1	$2.3M	Buy	287,779 +60,929	+27%	+$1.33M	0.01%	1534
2017 Q4	$6.31M	Sell	226,850 -25,253	-10%	-$670K	0.01%	914
2017 Q3	$6.81M	Sell	252,103 -1,216	-0.5%	-$31.8K	0.02%	877
2017 Q2	$7.38M	Buy	253,319 +85,213	+51%	+$2.59M	0.02%	798
2017 Q1	$5.73M	Buy	+168,106	New	+$5.42M	0.02%	938

Other funds holding DERM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Guggenheim Capital's DERM Position: Q2 2018 in Review

Guggenheim Capital sold out of Dermira, Inc. (DERM) in Q2 2018, closing a stake of 287,779 shares — an estimated $2.3M sold.

Guggenheim Capital first reported a position in DERM in Q1 2017 and held it in 5 quarters. The position peaked at $7.38M in Q2 2017. 119 funds tracked by Wall St. Rank hold DERM as of Q2 2018.

Guggenheim Capital reported no remaining Dermira, Inc. position as of Q2 2018 after selling out during the quarter.
Guggenheim Capital sold 287,779 Dermira, Inc. shares in Q2 2018, an estimated $2.3M.
Guggenheim Capital first reported a position in Dermira, Inc. in Q1 2017 and held it in 5 quarters.
Guggenheim Capital's Dermira, Inc. position peaked at $7.38M in Q2 2017.
119 funds tracked by Wall St. Rank held Dermira, Inc. as of Q2 2018.

Based on Guggenheim Capital's 13F filing for Q2 2018, filed 14 Aug 2018.